Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery

References

• Abdel-Bar HM, Abdel-Reheem AY, Awad GA, Mortada ND. (2013). Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam. J Pharm Pharm Sci 16:456–69
   PubMed Web of Science ®Google Scholar
• Aftab N, Vieira A. (2010). Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals. Phytother Res 24:500–2
   PubMed Web of Science ®Google Scholar
• Agrawal R, Mishra B, Tyagi E, et al. (2010). Effect of curcumin on brain insulin receptors and memory functions in STZ(ICV) induced dementia model of rat. Pharmacol Res 61:247–52
   PubMed Web of Science ®Google Scholar
• Amri A, Chaumeil JC, Sfar S, Charrueau C. (2012). Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 158:182–93
   PubMed Web of Science ®Google Scholar
• Amri A, Le Clanche S, Therond P, et al. (2014). Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death. Eur J Pharm Biopharm 86:418–26
   PubMed Web of Science ®Google Scholar
• Basavaraj S, Betageri GV. (2014). Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol. Expert Opin Drug Deliv 11:493–503
   PubMed Web of Science ®Google Scholar
• Bshara H, Osman R, Mansour S, El-Shamy Ael H. (2014). Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats. Carbohydr Polym 99:297–305
   PubMed Web of Science ®Google Scholar
• Caddeo C, Manconi M, Fadda AM, et al. (2013). Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation. Colloids Surf B Bionterfaces 111:327–32
   PubMed Web of Science ®Google Scholar
• Caddeo C, Teskac K, Sinico C, Kristl J. (2008). Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 363:183–91
   PubMed Web of Science ®Google Scholar
• Chen X, Zhi F, Jia X, et al. (2013). Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. J Pharm Pharmacol 65:807–16
   PubMed Web of Science ®Google Scholar
• Coimbra M, Isacchi B, van Bloois L, et al. (2011). Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm 416:433–42
   PubMed Web of Science ®Google Scholar
• Coradini K, Lima FO, Oliveira CM, et al. (2014). Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects. Eur J Pharm Biopharm 88:178–85
   PubMed Web of Science ®Google Scholar
• Davidov-Pardo G, McClements DJ. (2015). Nutraceutical delivery systems: resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. Food Chem 167:205–12
   PubMed Web of Science ®Google Scholar
• Donsi F, Sessa M, Mediouni H, et al. (2011). Encapsulation of bioactive compounds in nanoemulsion based delivery systems. Procedia Food Sci 1:1666–71
   Google Scholar
• Frozza RL, Salbego C, Bernardi A, et al. (2011). Incorporation of resveratrol into lipid-core nanocapsules improves its cerebral bioavailability and reduces the Aβ-induced toxicity. Alzheimers Dement 7:S114
   Google Scholar
• Gabal YM, Kamel AO, Sammour OA, Elshafeey AH. (2014). Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm 473:442–57
   PubMed Web of Science ®Google Scholar
• Gregori M, Masserini M, Mancini S. (2015). Nanomedicine for the treatment of Alzheimer's disease. Nanomedicine (Lond) 10:1203–18
   PubMed Web of Science ®Google Scholar
• Holland ML, Panetta JA, Hoskins JM, et al. (2006). The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochem Pharmacol 71:1146–54
   PubMed Web of Science ®Google Scholar
• Horvát S, Fehér A, Wolburg H, et al. (2009). Sodium hylauronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue. Eur J Pharm Biopharm 72:252–9
   PubMed Web of Science ®Google Scholar
• Ibrahim HK, El-Leithy IS, Makky AA. (2010). Mucoahesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone biotherapy. Mol Pharm 7:576–85
   PubMed Web of Science ®Google Scholar
• Kumar A, Naidu PS, Seghal N, Padi SS. (2007). Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79:17–26
   PubMed Web of Science ®Google Scholar
• Kumar M, Misra A, Babbar AK, et al. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 358:285–91
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Furuie H, Inano A, et al. (2012). Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Br J Pharmacol 166:1793–803
   PubMed Web of Science ®Google Scholar
• Loscher W, Potschka H. (2005). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86–98
   PubMedGoogle Scholar
• Lovelyn C, Attama A. (2011). Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol 2:626–39
   Google Scholar
• Lucas-Abellán C, Fortea I, López-Nicolás JM, Nunez-Delicado E. (2007). Cyclodextrins as resveratrol carrier system. Food Chem 104:39–44
   Web of Science ®Google Scholar
• Ma T, Tan MS, Yu JT, Tan L. (2014). Resveratrol as a therapeutic agent for Alzheimer's disease. Biomed Res Int 2014:350516
   PubMedGoogle Scholar
• Mahajan HS, Dinger SB. (2011). Design and in vitro evaluation of nanoemulsion for nasal delivery of artemether. IJNDD 3:272–7
   Google Scholar
• Monroy A, Lithgow GJ, Alavez S. (2013). Curcumin and neurodegenerative diseases. Biofactors 39:122–32
   PubMed Web of Science ®Google Scholar
• Moorthi C, Senthil Kumar C, Mohan S, et al. (2013). Application of validated RP-HPLC-PDA method for the simultaneous estimation of curcumin and piperine in Eudragit E 100 nanoparticles. J Pharm Res 7:224–9
   Google Scholar
• Nabekura T. (2010). Overcoming multidrug resistance in human cancer cells by natural compounds. Toxins (Basel) 2:1207–24
   PubMed Web of Science ®Google Scholar
• Nasr M, Awad GA, Mansour S, et al. (2011). Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm 79:601–11
   PubMed Web of Science ®Google Scholar
• Nasr M, Mansour S, Mortada ND, El Shamy AA. (2008a). Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS Pharm Sci Tech 9:154–62
   PubMed Web of Science ®Google Scholar
• Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008b). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 25:499–512
   PubMed Web of Science ®Google Scholar
• Nasr M, Nawaz S, Elhissi A. (2012). Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int J Pharm 436:611–16
   PubMed Web of Science ®Google Scholar
• Nasr M, Taha I, Hathout RM. (2013). Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route. Drug Deliv 20:311–18
   PubMed Web of Science ®Google Scholar
• Rachmawati H, Budiputra DK, Mauludin R. (2015). Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm 41:560–6
   PubMed Web of Science ®Google Scholar
• Sahni JK, Doqqui S, Ali J, et al. (2011). Neurotherapeutic applications of nanoparticles in Alzheimer's disease. J Control Release 152:208–31
   PubMed Web of Science ®Google Scholar
• Scheepens A, Tan K, Paxton JW. (2010). Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes Nutr 5:75–87
   PubMed Web of Science ®Google Scholar
• Sessa M, Balestrieri ML, Ferrari G, et al. (2014). Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. Food Chem 147:42–50
   PubMed Web of Science ®Google Scholar
• Sessa M, Tsao R, Liu R, et al. (2011). Evaluation of the stability and antioxidant activity of nanoencapsulated resveratrol during in vitro digestion. J Agric Food Chem 59:12352–60
   PubMed Web of Science ®Google Scholar
• Sharma M, Gupta YK. (2002). Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71:2489–98
   PubMed Web of Science ®Google Scholar
• Shen H, Shi S, Zhang Z, et al. (2015). Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells. Theranostics 5:755–71
   PubMed Web of Science ®Google Scholar
• Sood S, Jain K, Gowthamarajan K. (2013). Intranasal delivery of curcumin-/INS; donepezil nanoemulsion for brain targeting in Alzheimer's disease. J Neurol Sci 333:e316–17
   Google Scholar
• Sood S, Jain K, Gowthamarajan K. (2014). Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces 113:330–7
   PubMed Web of Science ®Google Scholar
• Sun AY, Wang Q, Simonyi A, Sun GY. (2010). Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 41:375–83
   PubMed Web of Science ®Google Scholar
• Tavano L, Muzzalupo R, Picci N, de Cindio B. (2014). Co-encapsulation of lipophilic antioxidants into niosomal carriers: percutaneous permeation studies for cosmeceutical applications. Colloids Surf B Biointerfaces 114:144–9
   PubMed Web of Science ®Google Scholar
• Vanaja K, Wahl MA, Bukarica L, Heinle H. (2013). Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin. Life Sci 93:917–23
   PubMed Web of Science ®Google Scholar
• Yang F, Lim GP, Begum AN, et al. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J Biol Chem 280:5892–901
   PubMed Web of Science ®Google Scholar